248 related articles for article (PubMed ID: 25844040)
1. The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies.
Chenel V; Boissy P; Poirier MS; Cloarec JP; Patenaude J
Int J Nanomedicine; 2015; 10():2125-37; quiz 2138-9. PubMed ID: 25844040
[TBL] [Abstract][Full Text] [Related]
2. Effects of disciplinary cultures of researchers and research trainees on the acceptability of nanocarriers for drug delivery in different contexts of use: a mixed-methods study.
Chenel V; Boissy P; Cloarec JP; Patenaude J
J Nanopart Res; 2015; 17(4):186. PubMed ID: 25960687
[TBL] [Abstract][Full Text] [Related]
3. Analyses of Acceptability Judgments Made Toward the Use of Nanocarrier-Based Targeted Drug Delivery: Interviews with Researchers and Research Trainees in the Field of New Technologies.
Chenel V; Boissy P; Cloarec JP; Patenaude J
Nanoethics; 2015; 9(3):199-215. PubMed ID: 26594255
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery.
Zou H; Wang Z; Feng M
J Control Release; 2015 Sep; 214():121-33. PubMed ID: 26208425
[TBL] [Abstract][Full Text] [Related]
5. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
6. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
7. In vitro toxicity assessment of oral nanocarriers.
Ciappellano SG; Tedesco E; Venturini M; Benetti F
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):381-401. PubMed ID: 27544694
[TBL] [Abstract][Full Text] [Related]
8. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
Mahajan K; Bhattacharya S
Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
[TBL] [Abstract][Full Text] [Related]
9. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature.
Karabasz A; Bzowska M; Szczepanowicz K
Int J Nanomedicine; 2020; 15():8673-8696. PubMed ID: 33192061
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.
Linton SS; Sherwood SG; Drews KC; Kester M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):208-22. PubMed ID: 26153136
[TBL] [Abstract][Full Text] [Related]
11. Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P; Cabral H; Kataoka K
Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
Witting M; Obst K; Friess W; Hedtrich S
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
[TBL] [Abstract][Full Text] [Related]
13. Nanocarriers as Administration Systems of Natural Products.
Solís-Cruz GY; Pérez-López LA; Alvarez-Roman R; Rivas-Galindo VM; Silva-Mares DA; Ibarra-Rivera TR
Curr Top Med Chem; 2021; 21(26):2365-2373. PubMed ID: 34525921
[TBL] [Abstract][Full Text] [Related]
14. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
Mehra NK; Jain K; Jain NK
Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
Andrade F; Videira M; Ferreira D; Sarmento B
Nanomedicine (Lond); 2011 Jan; 6(1):123-41. PubMed ID: 21182424
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers & drug delivery: rational design and applications.
Garcia-Fuentes M; Gonzalez-Díaz H; Csaba N
Curr Top Med Chem; 2014; 14(9):1095-6. PubMed ID: 24678712
[No Abstract] [Full Text] [Related]
18. Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics.
Akhter MH; Rizwanullah M; Ahmad J; Ahsan MJ; Mujtaba MA; Amin S
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):873-884. PubMed ID: 28830262
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients.
Chariou PL; Ortega-Rivera OA; Steinmetz NF
ACS Nano; 2020 Mar; 14(3):2678-2701. PubMed ID: 32125825
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
